Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Cancer Journal (Sudbury, Mass.)|July 23, 2013
PBRM1 and BAP1 as novel targets for renal cell carcinomaJames BrugarolasJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2014
Molecular genetics of clear-cell renal cell carcinomaJames BrugarolasThe Journal of Clinical Investigation|June 1, 2023
Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolitesDivya Bezwada, James BrugarolasCancer Cell|July 21, 2004
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromesJames Brugarolas, William G KaelinNature Protocols|October 19, 2013
Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applicationsSamuel Peña-Llopis, James BrugarolasHuman Pathology|August 6, 2022
The expanding role of BAP1 in clear cell renal cell carcinomaPayal Kapur, Satwik Rajaram, James BrugarolasCancer Journal (Sudbury, Mass.)|September 18, 2020
The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic OpportunitiesRoy Elias, Qing Zhang, James BrugarolasCancers|August 26, 2023
Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic SettingPayal Kapur, James Brugarolas, Kiril TrpkovCancer Cell|October 22, 2011
Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2Lisa Kinch, Nick V Grishin, James BrugarolasHuman Molecular Genetics|August 21, 2009
Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1Jing Zhou, James Brugarolas, Luis F ParadaPageof 18